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Objectives: We hypothesized reduction of 30 days’ in-hospital morbidity,
mortality, and length of stay postimplementation of the World Health Organi-
zation’s Surgical Safety Checklist (SSC).
Background: Reductions of morbidity and mortality have been reported after
SSC implementation in pre-/postdesigned studies without controls. Here, we
report a randomized controlled trial of the SSC.
Methods: A stepped wedge cluster randomized controlled trial was conducted
in 2 hospitals. We examined effects on in-hospital complications registered by
International Classification of Diseases, Tenth Revision codes, length of stay,
and mortality. The SSC intervention was sequentially rolled out in a random
order until all 5 clusters—cardiothoracic, neurosurgery, orthopedic, general,
and urologic surgery had received the Checklist. Data were prospectively
recorded in control and intervention stages during a 10-month period in 2009–
2010.
Results: A total of 2212 control procedures were compared with 2263 SCC
procedures. The complication rates decreased from 19.9% to 11.5% (P <
0.001), with absolute risk reduction 8.4 (95% confidence interval, 6.3–10.5)
from the control to the SSC stages. Adjusted for possible confounding factors,
the SSC effect on complications remained significant with odds ratio 1.95
(95% confidence interval, 1.59–2.40). Mean length of stay decreased by 0.8
days with SCC utilization (95% confidence interval, 0.11–1.43). In-hospital
mortality decreased significantly from 1.9% to 0.2% in 1 of the 2 hospi-
tals post-SSC implementation, but the overall reduction (1.6%–1.0%) across
hospitals was not significant.
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Conclusions: Implementation of the WHO SSC was associated with robust
reduction in morbidity and length of in-hospital stay and some reduction in
mortality.
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A s global surgical volume increase and exceed 234 million surgicalprocedures annually,1 surgical mortality has declined over the
previous decades.2 Still, crude mortality rates are reported to vary
between 0.4% and 4% in high-income countries.3–5 Increased risk
of mortality is associated with major complications in hospitals with
higher overall mortality.6 In-hospital complications occur in 3% to
22% of admitted patients, with 36% to 54% related to surgery.7–9
Prevention of complications and incidents of iatrogenic harm are
deemed feasible for nearly 50% of such incidents.3,9 Introduction of
checklists in surgery can intercept and prevent such incidents10–12 and
may reduce both morbidity and mortality.13–16
In 2008, the World Health Organization (WHO) introduced
the Surgical Safety Checklist (SSC) designed to improve consis-
tency of care.17 The pilot pre-/postevaluation of the WHO SSC
across 8 countries worldwide, which found reduced morbidity
and mortality after SSC implementation,14 constituted the first
scientific evidence of the WHO SSC effects. A number of subsequent
studies to date have reported improved patient outcomes with use
of checklists.18 Furthermore, checklists have also been shown to
improve communication,19–22 preparedness,23 teamwork,24,25 and
safety attitudes26—findings that have been corroborated by a recent
systematic review.27
Although checklists are becoming a standard of care in
surgery,28 the strength of the available evidence has been criticized
as being low because of (i) predominantly pre-/postimplementation
designs without controls; (ii) lack of evidence on effect on length of
stay; and (iii) lack of evidence on any associated cost savings. Ran-
domized controlled trials (RCTs) are required29—however, in some
countries or settings, they can no longer be carried out, as the WHO
SSC has already become national policy (eg, United Kingdom).
We report a stepped wedge cluster RCT aimed to evaluate
the impact of the WHO SSC on morbidity, mortality, and length of
hospital stay (LOS). We hypothesized a reduction of 30 days’ in-
hospital morbidity and mortality and subsequent LOS post-Checklist
implementation.
METHODS
Study Design
We conducted a stepped wedge cluster randomized controlled
checklist intervention trial in 2 hospitals in Norway30; a tertiary
teaching hospital (1100 beds) and a central community hospital (300
beds). Following the WHO implementation guidelines for the SSC,
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we invited 5 surgical specialties to participate; cardiothoracic, neu-
rosurgery, orthopedic, general, and urologic surgical procedures.31
None declined to participate. These 5 surgical specialties constituted
1 cluster each, in which patients underwent surgical procedures as
usual. The order of the checklist intervention was randomized and
sequentially rolled out until all 5 clusters had received the interven-
tion. The stepped wedge design is similar to a crossover design in
terms that the different clusters (here: surgical specialties) in turn
switched treatment from control (no checklist) to intervention (WHO
SSC) at different study time points. Furthermore, the clusters crossed
over in 1 direction only (ie, introduction of the checklist) and the
WHO SSC was not retracted after implementation (Figs. 1 and 2).
This stepped wedge cluster randomized design is particularly
relevant where it would be considered unethical to not deliver or
retract the intervention when it is predicted to do more good than
harm,30,32 as was the case here for the WHO SSC.14,16 Furthermore,
this design is useful in cases in which randomizing individual surgical
procedures to control and intervention (some procedures without the
WHO SSC, some with it) would be near-impossible or if possible
significantly affected by contamination effects. Finally, the stepped
wedge design is considered especially useful when it is not possible
to deliver the intervention to all participants (individuals or clusters)
at the same time for logistical, practical, or financial reasons.30 It
allows for the clusters to be their own controls and hence provide
all data in both control and intervention sections of the SSC stages
for comparison, thereby reducing possible contamination biases.33
One major disadvantage of the stepped wedge design might be that
it requires a large amount of data to be collected. Hence, such a
drawback could be mitigated by the use of routinely collected data.33
This study was reviewed by the Regional Committee for
Medical and Health Research Ethics (Ref: 2009/561), which ad-
vised that use of routinely collected anonymized patient data
is clinical service improvement and thus no further approval or
patient consent is required. Hence, the study was approved by
hospital privacy Ombudsmen (Ref: 2010/413) and local hospital
managers.
Checklist Intervention
The WHO SSC was first adapted to fit into the Norwegian
surgical care pathway.34 The Checklist consisted of 20 items and as
per WHO guidelines was performed at 3 critical steps of the surgical
procedure: the “sign in” before induction of anesthesia, the “time out”
before start of surgery, and the “sign out” before the head surgeon
left the operating room.17
The Checklist was implemented in clusters of surgical spe-
cialties consecutively numbered from 1 to 5. Randomization of the
stepped wedge intervention was determined by a draw of 5 num-
bers into a rank order deciding the sequential roll out of the in-
tervention. The assessor of the randomization (G.E.E.) was blinded
regarding which specialty corresponded to which number. After a
baseline registration period of 3 months, the SSC was implemented
consecutively into orthopedic, cardiothoracic, and neurosurgery at
the first hospital and then into general and urologic surgery at the
second hospital. These interventions were rolled out with a time pe-
riod of 3 to 4 weeks between these 5 randomized stepped wedges.
The SSC was introduced in all specialties/hospitals while using
an educational program with standardized lectures and information
materials.34
Outcome Measures
The primary endpoints of this study included both major and
minor complications and in-hospital mortality up to 30 days af-
ter surgery. The complications were all identified and defined us-
ing the WHO’s International Classification of Diseases, Tenth Revi-
sion (ICD-10) and classified into 11 categories (Supplemental Digital
Content 1, available at http://links.lww.com/BRS/A868).35 Secondary
endpoints included patients’ LOS.
Data Collection
The study population included all age groups and elective or
emergency surgery. Procedures not involving all 3 parts of the check-
list (ie, γ knife treatment or donor surgery) were excluded. Patient
FIGURE 1. Design of the stepped wedge cluster randomized controlled SSC trial in 2 hospitals in western Norway in 2009–2010.
Order of the SSC introduction to the clusters was randomized. White box indicates controls with care as usual; colored box, SSC
intervention.
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Assessed for eligibility (n=5460)
Excluded (n=165)
♦ Not meeting inclusion criteria
Gamma knife treatment (n=140)
Donor surgery (n=4)
Incomplete birth numbers (n=21)
Analysed (n=2212)
♦ Excluded from analysis (n=0)
Lost to follow-up (n=0)
Discontinued intervention (n=0)
Procedures allocated to control steps (n=2212)
♦ Received intervention (n=0)
♦ Received care as usual (n=2212)
Lost to follow-up (n=0)
Discontinued intervention (n=0)
Procedures allocated to intervention steps (n=3083)
♦ Received allocated intervention (n=2263)
♦ Did not comply to allocated intervention
Partial-compliance to intervention (n=613)
Non-compliance to intervention (n=207)
Analysed (n=2263)
♦ Excluded from analysis (n=0)
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FIGURE 2. CONSORT 2010 flow diagram of the stepped wedge cluster randomized Surgical Safety Checklist intervention trial.
characteristics including age, sex, and comorbidity (American Soci-
ety of Anesthesiologists score) were obtained from hospital admin-
istrative data. Types of surgery, form of anesthesia, and LOS were
collected. Data were registered electronically by nurse anesthetists,
operating room nurses, anesthetists, and surgeons in the operating
room per regular practice (alongside other data). To reduce informa-
tion bias, the clinicians were not informed as to which endpoints were
measured during the study. Compliance with the SSC was assessed
by nurse anesthetists and operating room nurses while performing
the Checklist. This prospective assessment was performed on a pro
forma and also registered in the operating room electronic database.
Outcome data on all patients were extracted from the hospitals’ ad-
ministrative databases and collected by research assistants. Mortality
was assessed from the public mortality register. All postoperative
complications were prospectively assigned ICD-10 codes by the sur-
geons or ward doctors as per routine practice in the hospitals at
patients’ discharge.
Data Handling
All research assistants were blinded to the randomization of
patients into intervention and control cohorts when they handled
the data and evaluated data quality. Quality check of the extracted
data included a random analysis of 360 cases to check whether data
concurred with the original patient administrative data. There were
discrepancies in 1.7% (6/360) for names, 0.8% (3/360) for proce-
dure and diagnostic codes, and 0.3% (1/360) for operation times and
100% match for remaining data variables. Variation was mainly due
to differences between manually registered Checklist data and elec-
tronically recorded data, of which the latter was used for analysis. All
ICD-10 codes predefined as complications were identified and coded
as complications and quality rechecked against the patients’ medical
records. The complication codes were checked for relevance to the
actual surgical procedure to ensure that they were true complications
and not merely an indication for surgery. The in-hospital mortality
was associated to the unique patient and coded with “0” if alive at dis-
charge/or after 30 days or “1” if mortality occurred before discharge
within 30 days postoperatively.
Data from the postintervention cases (n = 3083) were han-
dled as the total intervention group and included cases with non-
compliance (intention to treat), partial compliance, and full compli-
ance to the SSC. To investigate the SSC effects of full compliance,
data from these cases (n = 2263) were handled separately in the
analysis.
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Statistical Analysis
The surgical specialty cohorts acted as their own controls and
hence provided data in all steps of the wedge, before and after the
Checklist intervention, thus reducing risk of bias. Analyses of stepped
wedge RCTs involve comparing all data in the steps before (controls)
with the steps after the intervention.33 Accordingly, all patient char-
acteristics for the controls and postimplementation of the SSC were
compared using Pearson exact χ 2 test (categorical data) or with inde-
pendent samples t test (numerical data) as appropriate. Furthermore,
calculations on absolute risk reduction and relative risk reduction of
morbidity and mortality with 95% confidence intervals (CIs) were
based on Pearson exact χ 2 test with Bonferroni correction. For para-
metric analyses, effect sizes were calculated with η2 defined as small
(0.01), medium (0.06), or large (0.14).36 Numbers needed to treat
were used to calculate the preventive effect of the Checklist.37 The
sample size needed to detect a decrease in the mortality rate (in the
first 30 days) from 0.08 to 0.06 at significance level 5% with 91%
power was calculated to be 1110 in each group (without/with use
of checklist). Intracluster correlation is considered to have minimal
effect on power due to the unidirectional stepped wedge implementa-
tion of the intervention30; hence, it was not calculated. Binary logistic
regression was used to adjust the Checklist effect on mortality and
morbidity for possible confounding factors. Any difference in com-
plication rates and procedure complexity in each surgical specialty
between pre and postintervention was controlled for in the regression
model with interactions. “Time” (study time points) was entered into
the model to adjust for variation in complication rates at the different
study time points throughout, as well as comorbidity (and other risk
factors as age, surgical specialty, elective or emergency surgery, and
type of anesthesia). Comparison of LOS before and after checklist
implementation was tested by independent samples t test. For all anal-
yses, a 2-sided P value of less than 0.05 was considered statistically
significant. Statistical analysis was performed using SPSS version
21.0 (IBM Corp., Armonk, NY).
RESULTS
A total of 5295 surgical procedures were carried out through-
out the stepped wedge cluster RCT, that is, 2212 in control and
3083 (of which 2263 had the SSC performed) after implementa-
tion of the SSC. Patients (14.9%; 667/4475) underwent more than
1 procedure. The control and SSC study steps included 1778 and
2033 unique patients, respectively. Characteristics of patients and
their distribution across study steps are reported in Table 1. Pa-
tients did not differ in sex, age, or comorbidity between the con-
trol/SSC stages. However, patients were more likely to undergo or-
thopedic and emergency surgery and regional anesthesia in the SSC
than the control cohort (P < 0.001). Compliance with the SSC was
73.4%.
The overall complication rate during the study period was
15.7% and decreased from 19.9% in the control steps to 11.5%
in the SSC steps (P < 0.001) (Table 2). Absolute risk reduction
was 7.5 (95% CI, 5.5–9.5) post-Checklist implementation when all
procedures (3083) were included. Absolute risk reduction was 8.4
(95% CI, 6.3–10.5) when all 3 parts of the SSC were used. Rel-
ative risk reduction was 0.42 (95% CI, 0.33–0.50). A large effect
size by parametric η2 at 0.14 was found. Number needed to treat
(overall Checklist use) in order to prevent one of these complica-
tions was 12 (95% CI, 9–16). Using logistic regression, we adjusted
the Checklist effect on complications for possible confounding fac-
tors including sex, age, comorbidity (American Society of Anes-
thesiologists score), surgical specialty, urgency of surgery, type of
anesthesia, and times (this refers to study time points from August
2009 to June 2010). Even with these adjustments, the Checklist re-
TABLE 1. Characteristics of Patients in the Stepped Wedge
Cluster Randomized Controlled Trial in 2 Hospitals in
Western Norway in 2009–2010
Control SSC P
All procedures (n) 2212 3083
Procedures with all parts
of checklist used
2212 2263
>1 procedure (%) 19.6 10.2 < 0.001
Unique patients (n) 1778 2033
Mean age in years (SD) 54.1 ± 23.0 54.3 ± 23.3 0.869
Male sex (%) 55.6 55.9 0.718
Comorbidity by ASA (%) 0.272
ASA I 21.8 24.0
ASA II 43.3 43.5
ASA III 31.3 29.6
ASA IV 3.4 2.9
ASA V 0.1 0.0
No ASA score (n) 87 73
Surgical specialty (%) < 0.001
Orthopedic 32.7 55.3
Thoracic 13.4 12.5
Neuro 17.6 9.3
General∗ 27.0 16.9
Urologic 9.3 5.9
Surgery (%) 0.001
Elective 59.0 54.2
Emergency 41.0 45.8
Anesthesia < 0.001
Regional 31.8 45.3
General 68.2 54.7
Patients by hospitals (%) < 0.001
Tertiary hospital 63.7 77.2
Central community
hospital
36.3 22.8
Mean length of in-hospital
stay (d)
7.8 7.0 0.022
P value indicates Pearson exact χ2 test with Bonferroni correction and indepen-
dent samples t test for continuous variables. Significant values are in bold.
∗Includes procedures with gastrointestinal, endocrine, and plastic surgery.
ASA indicates American Society of Anesthesiologists comorbidity/risk score.
mained significantly related to complication outcome, with OR of
1.95 (95% CI, 1.59–2.40) in the final regression model (Table 3).
To control for possible differences in complication rates and com-
plexity within surgical specialties from pre- to postintervention, we
adjusted for interactions with time (study time points). In the final
step, the Checklist effect remained with OR 1.84 (95% CI, 1.27–2.65).
Checklist introduction resulted in significant decreases of complica-
tions in 4 of the 5 surgical specialties included but not in general
surgery.
The overall in-hospital mortality rate during the whole study
period was 1.3% and decreased from 1.6% in the control steps to 1.0%
in the steps after SSC implementation (P = 0.151). The result did not
change after controlling for possible confounders including sex, age,
comorbidity (American Society of Anesthesiologists score), surgical
specialty, urgency of surgery, type of anesthesia, and times (study
time points from August 2009 to June 2010) (Supplemental Digital
Content 2, available at http://links.lww.com/BRS/A868). Analysis of
mortality by hospital revealed a significant decrease from 1.9% to
0.2% (P = 0.020) post-SSC implementation in the smaller community
hospital of the study.
Patients’ LOS was compared at control and SSC intervention
stages of the study. The total in-hospital LOS for both study hospitals
was significantly reduced from 7.8 days to 7.0 days after introduction
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TABLE 2. Morbidity and Mortality Outcome of the Stepped Wedge Cluster Randomized Controlled Trial in 2 Hospitals in
Western Norway in 2009–2010
ARR
Procedures (n = 4475) With
1 or More Complications Control (%) SSC (%) Percent Points 95% CI P
Respiratory complication 6.4 3.2 <0.001
Pneumonia 3.7 1.9 <0.001
Respiratory failure 1.0 0.5 0.062
Other∗ 1.8 0.8 0.008
Cardiac complication 6.4 4.3 0.004
Cardiac arrest 0.5 0.4 0.644
Arrhythmia 3.3 2.7 0.188
Congestive heart failure 0.7 0.3 0.061
Acute myocardial infarction 1.0 0.5 0.062
Angina pectoris 0.9 0.4 0.058
Infections 6.0 3.4 <0.001
Sepsis 0.6 0.3 0.075
Surgical site 2.2 1.5 0.149
Urinary tract 2.8 1.4 0.001
Other† 0.7 0.3 0.089
Surgical wound rupture 1.2 0.3 <0.001
Nervous system complication‡ 0.5 0.3 0.232
Bleeding§ 2.3 1.2 0.008
Embolism¶ 0.5 0.2 0.092
Mechanical implant complication 1.1 0.4 0.005
Anesthesia complication 0.3 0.2 0.772
All other complications|| 2.0 0.7 <0.001
Unplanned return to
operating theatre
1.7 0.6 <0.001
Complications (SSC) 19.9 11.5 8.4 6.3–10.5 <0.001
Complications in all
(n = 2212/3083)
19.9 12.4 7.5 5.5–9.5 <0.001
In-hospital death (n = 3811)
Tertiary hospital
(n = 2715)
1.4 1.3 0.1 −0.7–1.1 0.865
Central hospital (n = 1083) 1.9 0.2 1.7 0.4–3.0 0.020
Total deaths 1.6 1.0 0.5 −0.2–1.3 0.151
P value indicates Pearson exact χ2 test. Significant values are in bold. No interactions between SSC and the other variables in the final model were significant.
∗Including asthma, pleura-effusion, and dyspnea.
†Including meningitis, peri- and endocarditis, and gastroenteritis.
‡Including delirium and somnolence.
§Bleeding: A complication to surgical or medical procedures and valid for major or severe acute bleedings associated with the surgical procedure that required erythrocyte
transfusions unplanned for and noted in the medical record by the surgeon.
¶Including arterial-, venous-, lung-, and air emboli.
||Including circulatory collapse, unintended punctures or lacerations, kidney failure, complications after surgical and medical procedures, and complications to surgery not
classified.
ARR indicates absolute risk reduction.
of the Checklist, with a mean difference of −0.8 days, t = 2.30 (95%
CI, 0.11–1.43). Furthermore, there were no significant changes in
length of surgery or in total time spent in the operating room.
DISCUSSION
Comparison With Other Studies
To our knowledge, this is the first stepped wedge cluster RCT
on the clinical effectiveness of the WHO SSC. The study showed
substantial improvements in surgical outcomes. Across 2 hospitals of
a well-developed and funded health care system (Norway) including
5 surgical specialties, complication rates fell by 42% on average when
the SSC was introduced. The effect was largest when all 3 parts of the
SSC were conducted. The effect was significant even when surgical
procedures included “intention to treat” with the SSC (in all 3083 sur-
gical procedures postintervention, Table 2). The findings support our
hypothesis and are consistent with previous pre-/poststudies having
found similar effects of the WHO Checklist use.14–16 Our results of
reduction in morbidity also correspond to findings on use of the com-
prehensive “surgical patient safety checklist system” (SURPASS) in
The Netherlands.13
The in-hospital stay decreased significantly in this study by
almost a day. This is the first time the WHO SCC is shown to reduce
LOS. The finding is consistent with a reduction in LOS by 0.6 days
previously obtained after introducing the SURPASS checklist, which,
however, did not reach statistical significance.13 Furthermore, our
study reflects similar findings in intensive care units, where LOS has
been significantly reduced after use of a daily checklist (goal sheet).38
LOS reduction provides a potential of significant cost savings in
surgical care by improved patient outcome, as costs of complications
and unplanned returns to operating room are reduced.39 Although
the WHO SSC was designed for quality improvement, a secondary
effect—cost savings—should further encourage health care leaders
to adopt and support its use.
After implementation of the WHO SSC, the overall study mor-
tality deceased from 1.6% to 1.0% but did not improve significantly
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TABLE 3. Results From Logistic Regression Analyses of Complications on Patient and Treatment Variables in the Stepped
Wedge Cluster Randomized Controlled Trial of the WHO SSC in 2 Hospitals in Norway in 2009–2010
Unadjusted Fully Adjusted Final Model∗
n OR 95% CI P OR 95% CI P OR 95% CI P
Absence of the WHO SSC
(after = reference)
2212 (2263) 1.91 1.62–2.26 <0.001 2.01 1.40–2.88 <0.001 1.95 1.59–2.40 <0.001
Age 4475 1.03 1.02–1.03 <0.001 1.01 1.01–1.02 <0.001 1.01 1.01–1.02 <0.001
Male sex (female =
reference)
2516 (1959) 1.32 1.12–1.55 0.001 1.14 0.93–1.40 0.205 — —
Comorbidity by ASA score 4266 <0.001 <0.001 <0.001
Healthy (reference) 977 1 1 1
Mild systemic disease 1852 3.04 2.06–4.50 2.42 1.59–3.69 2.41 1.59–3.68
Moderate systemic disease 1298 14.09 9.67–20.53 5.74 3.69–8.94 5.78 3.70–8.93
Severe systemic disease 135 25.92 15.84–42.41 8.14 4.60–14.40 8.15 4.61–14.41
Morbid 4 91.55 9.26–905.19 23.71 1.54–365.39 23.98 1.54–373.27
Surgical specialty 4475 <0.001 <0.001 <0.001
Orthopedic (reference) 1975 1 1 1
Cardiothoracic 580 8.40 6.75–10.45 8.15 5.56–11.96 8.49 5.82–12.40
Neuro 600 1.27 0.96–1.68 1.61 1.12–2.33 1.66 1.16–2.38
General 981 1.24 0.97–1.57 1.61 1.16–2.24 1.64 1.19–2.26
Urology 339 0.71 0.46–1.09 1.02 0.62–1.68 1.09 0.67–1.77
Surgery emergency
(elective = reference)
2532 (1943) 1.18 1.00–1.39 0.045 3.18 2.45–4.12 <0.001 3.19 2.46–4.13 <0.001
Anesthesia† general
(regional = reference)
2528 (1588) 1.78 1.48–2.15 <0.001 1.56 1.19–2.04 0.001 1.55 1.18–2.03 0.002
Time: Study time points 4475 0.90 0.88–0.93 <0.001 1.01 0.94–1.07 0.884 — —
P values in the regression model are based on the likelihood ratio test.
∗Backward stepwise selection from the fully adjusted model at P < 0.05, with SSC entered into all models. No interactions between SSC and the other variables in the final
model were significant.
†General anesthesia included patients induced with anesthesia requiring respirator support through laryngeal mask or endotracheal tubes. Regional anesthesia included patients
anesthetized through epidural-, spinal-, or plexus anesthesia. Combinations of regional and general anesthesia were classified as general anesthesia.
ASA indicates American Society of Anesthesiologists; OR, odds ratio; WHO SSC, World Health Organization Surgical Safety Checklist.
(P = 0.151). However, we observed a highly significant reduction of
mortality from 1.9% to 0.2% (P = 0.02) in the smaller community
hospital (albeit on fewer cases due to small hospital size), with a
relative risk reduction of 91%. The Checklist effect on mortality was
thus present but weaker in our RCT than in previous reports from
pre-/postintervention studies.13–16
Strengths and Limitations of This Study
In our view, this study’s major contribution to our better un-
derstanding of Checklist effects lies in its stepped wedge cluster RCT
design. Such designs have been considered unfeasible because in
countries such as the United Kingdom, the WHO SSC is now na-
tional policy (and hence a control arm is not available) and also due
to contamination and biases resulting from “control” operating room
teams treating control patients as patients assigned to the checklist
arm.13 However, such contaminations and biases were minimized
by randomization of the study clusters in “stepped wedges.”33 Each
cluster acted as its own control and hence provided data in both the
control and SSC stages, comparable with a crossover design, with
all data being compared between the control and SSC stages. To
reduce uncertainty of variation in surgical procedure complication
rates and complexity within each cluster from pre- to postinterven-
tion, we adjusted for possible risk factors as age, sex, comorbidity,
surgical specialty, emergency or planned surgery, type of anesthesia,
and time (study time points). The stepped wedges provided the pos-
sibility to control complication and morbidity for time effects during
the study period. Complications rates varied at different study time
points but when controlled for, time was not a confounding factor for
the Checklist effect on complications (Table 3). The stepped wedge
cluster RCT design is considered particularly appropriate for studying
patient safety interventions.30,32 To control for leakage and possible
contamination of surgeons between the 2 hospitals and the 5 surgical
specialties, we did not include the same surgical specialty in both
hospitals. The SSC was first introduced to the intervention groups.
Hence, any possible contamination would have leaked from the inter-
vention group to improve care in the controls, eventually. The results
do not suggest that this was apparent.
The degree of blinding is important for the validity of RCTs,
and in our study, operating room staff were not informed of the
study outcomes, as they routinely registered the patient data on the
electronic data system of their operating rooms. To further prevent
information bias, the outcome assessors were masked to which cohort
(control and SSC stages) patients were enrolled. Furthermore, to
reduce the risk of performance and information bias, all recovery and
ward staff carried out care as usual and were blinded to the study
cohorts and outcomes, following the extended CONSORT statement
for nonpharmacological randomized trials.40
Our study has several limitations. First, the clusters that had
not yet received the intervention could have been contaminated by
possible enthusiasm for the SSC from colleagues in other specialties
that were in the SSC study stage. Such bias would have likely mini-
mized any positive effects of the Checklist. The substantial and robust
decrease of complications that we found suggests that such bias did
not affect the study significantly. A second limitation is the way in
which the data were registered. A selection of ICD-10 codes was used
to identify complications. It is possible that surgeons and ward doctors
reported the ICD-10 codes variably. As far as we could account for,
there were no changes in the ICD-10 code implemented during the
study period. Furthermore, variable recording would equally affect
the control and the SSC stages of the study. A final limitation is that
Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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recording of complications was confined to the in-hospital admis-
sion period. Data on complications after discharge were not recorded
or obtained. The total number of postoperative complications could,
therefore, be higher. A more extensive follow-up of the patients after
discharge would be beneficial in future studies, though costly.
Further Research
Further research should investigate how use of the SSC and
other checklists achieves its positive impact on patient outcomes. Im-
proved outcomes post–checklist implementation have been explained
by improvements in communication and teamwork in the operating
room27 and a wider improvement in safety attitudes.20,22,24–26 In a
concurrent with this study evaluation of the impact of the introduc-
tion of the WHO SSC on patient safety climate in operating rooms,
we did not find the hypothesized improvement in culture—although
we did find that operating room teams reported being better able
to handle a complex situation when the Checklist is used.34 We also
anecdotally observed that the introduction of the WHO SSC drove be-
havior change, as the team members paused, introduced themselves,
and carried out team briefings prior to the operative list. Such behav-
ioral changes may precede deeper changes in organizational safety
culture—which may in turn underline the sustainability of long-term
appropriate implementation of a checklist and improved patient out-
comes. These questions require longitudinal controlled research de-
signs to be addressed.
CONCLUSIONS
This stepped wedge cluster RCT adds to this growing body of
evidence on the positive effects on patient outcomes driven by the
WHO SSC. We conclude that the use of the WHO Checklist prevents
complications and reduces in-hospital length of stay and potentially
also mortality across a wide range of patients undergoing simple or
complex surgical procedures in hospitals within a well-developed and
funded health care system.
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